Eptifibatide
Eptifibatide is a pharmaceutical drug with 18 clinical trials. Historical success rate of 76.5%.
Success Metrics
Based on 13 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
9
Mid Stage
8
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
76.5%
13 of 17 finished
23.5%
4 ended early
0
trials recruiting
18
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Multi-arm Optimization of Stroke Thrombolysis
Shortened Aggrastat® Versus Integrilin in Percutaneous Coronary Intervention
Crushed Ticagrelor Versus Eptifibatide Bolus + Clopidogrel
Ticagrelor and Eptifibatide Bolus-Only Versus Ticagrelor and Eptifibatide Bolus Plus Abbreviated Infusion
Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy
Clinical Trials (18)
Multi-arm Optimization of Stroke Thrombolysis
Shortened Aggrastat® Versus Integrilin in Percutaneous Coronary Intervention
Crushed Ticagrelor Versus Eptifibatide Bolus + Clopidogrel
Ticagrelor and Eptifibatide Bolus-Only Versus Ticagrelor and Eptifibatide Bolus Plus Abbreviated Infusion
Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy
Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke (CLEAR-FDR)
Study of Otamixaban Versus Unfractionated Heparin (UFH) and Eptifibatide in Non-ST Elevation Acute Coronary Syndrome
Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke
BRIEF-PCI: Brief Infusion of Eptifibatide Following Percutaneous Coronary Intervention
Clinical Effects of Eptifibatide Administration in High Risk Patients Presenting With Non-ST Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Urgent Coronary Artery Bypass Graft Surgery in Short- and Long-Term Follow-up
A Safety Study of Eptifibatide in Patients With Sickle Cell Disease
Combination Anti-Platelet and Anti-Coagulation Treatment After Lysis of Ischemic Stroke Trial (CATALIST)
Efficacy Of Eptifibatide Compared To Abciximab In Primary Percutaneous Coronary Intervention (PCI) For Acute ST Elevation Myocardial Infarction (STEMI)
A Safety/Efficacy Study of Intracoronary Integrilin to Improve Balloon Angioplasty Outcomes for the Treatment of Heart Attacks
The INtegrilin Plus STenting to Avoid Myocardial Necrosis Trial (INSTANT)
INSTANT: INtegrilin Plus STenting to Avoid Myocardial Necrosis Trial
Effectiveness of Intracoronary Injection of Eptifibatide in Primary Coronary Intervention in STEMI Patients
Randomized Study of Aspirin Resistant Patients Undergoing Angioplasty
All 18 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 18